Industry Sessions
Corporate Industry Symposia
Thursday, 22 October 2020
Amgen-sponsored corporate satellite symposium at ECTS 2020
Time: 13.45–15.15
Live Stream 1
13:45 – 15:15
13:45 – 13:50
13:50 – 14:15
14:15 – 14:40
14:40 -15:05
15:05 – 15:15
Satellite Symposium Amgen (Europe) GmbH : Optimising Bone Health: recognising and treating a wide patient spectrum – Chairs : Roland Chapurlat (France) & Richard Eastell (UK)
Welcome and Introduction – Roland Chapurlat (France) & Richard Eastell (UK)
What is the optimal long-term treatment sequence for osteoporosis patient ? – Richard Eastell (UK)
Bone sweet bone; how diabetes mellitus impair bone quality – Lorenz Hofbauer (Germany)
Clinical updates in osteogenesis imperfecta – Jorg Oliver Semler (Germany)
Q&A and close – Richard Eastell (UK)
Friday, 23 October 2020
Ipsen Pharma -sponsored corporate satellite symposium at ECTS 2020
Time: 13.45–15.15
Live Stream 1
13:45 – 15:15
13:45 – 14:00
14:00 – 14:20
14:20 – 14:40
14:40 – 15:00
15:00 – 15:15
Satellite Symposium Ipsen Pharma : What can we learn from the FOP community ? – Chairs : Valerie Cormier-Daire (France)
Chairperson’s welcome and introduction – Valerie Cormier-Daire (France)
Ten things we have learned about FOP in the last 30(0) years – Richard Keen (UK)
Understanding the natural history and other special considerations for clinical trials in FOP – Heike Hoyer-Kuhn (Germany)
Patient-driven data in rare bone diseases : A concrete example from the FOP Registry – Sammi Kile (United States)
Panel discussions and conclusions – Valerie Cormier-Daire (FOP)
Saturday, 24 October 2020
UCB-sponsored satellite symposium at ECTS 2020
Time: 13:45 – 15:15
Live Stream 1
13:45 – 15:15
13:45 – 13:50
13:50 – 14:10
14:10 – 14:30
14:30 – 14:50
14:50 – 15:10
15:10 – 15:15
Building stronger bones: a new approach to fracture management in severe osteoporosis – Chairs : Thierry Thomas (France)
Welcome and introduction – Thierry Thomas (France)
Improving bone strength in postmenopausal women with severe osteoporosis: An opportunity to take a different approach ? – John Carey (Ireland)
Mechanisms and effects of therapeutic interventions on bone microstructure and strength – Roland Baron (United States)
A new treatment option for postmenopausal women with severe osteoporosis – Bente Langdahl (Denmark)
Panel discussion
Conclusion and closing remarks – Thierry Thomas (France)
Corporate Mini Symposia
Friday, 23 October 2020
Gedeon Richter-sponsored mini corporate symposium at ECTS 2020
Time: 19:00 – 20:00
Live Stream 1
19:00 – 20:00
Mini Corporate Symposium Gedeon Richter : Bone Anabolic Treatment – The past, the present and the future – Chairs : Prof. Peyman Hadji
How to individualise treatment – an interactive case presentation – Peyman Hadji (Germany)
Friday, 23 October 2020
Inozyme Pharma-sponsored mini corporate symposium at ECTS 2020
Time: 19:00 – 20:00
Live Stream 2
19:00 – 20:00
19:00-19:10
19:10 – 19:20
19:20 – 19:35
19:35 – 19:50
19:50 – 20:00
Mini Corporate Symposium Inozyme Pharma, Inc: The Natural History of ENPP1 Deficiency: A Clinical Spectrum from GACI to ARHR2 – Chair: Pedro Huertas (United States)
Welcome
The key role of PPi in driving diseases of ectopic mineralization – Pedro Huertas (United States)
A Natural History of ENPP1 deficiency – Frank Rutsch (Germany)
GACI & ARHR2: Lessons learnt from a clinical case – Zulf Mughal (United Kingdom)
Discussion Time
More information soon…